Director, GCO Program Lead (GCPL)

BeiGene

3d•$171,900 - $231,900

About The Position

BeOne is seeking a Global Clinical Operations (GCO) Program Lead, open to Associate Director or Director-level candidates, with lung cancer experience. The role uses therapeutic-area expertise, global program management skills, and borderless leadership to guide strategic operational planning and clinical operational performance for designated programs. The Program Lead serves as an escalation point for study issues and leads global Clinical Study Management teams (gCSMs), supporting proactive risk management, mentorship, and talent development. The role partners with program leads and functional representatives across BeOne R&D to shape disease and asset strategy and ensure strong execution. It represents GCO in program governance, provides clinical operations insight, oversees program resources, budgets, planning, and study delivery, and contributes expertise in clinical trial execution and regulatory requirements. This is an international role involving colleagues across time zones. Travel may be required according to business needs.

Requirements

Bachelor’s degree or higher in a scientific or healthcare discipline.
At least 10 years of experience in the clinical trial industry.
Lung cancer experience.
Project management exposure or experience across the full lifecycle of multi-region or multi-country clinical trials in a fast-paced global environment.
Microsoft Office skills.
Expert knowledge of clinical trial execution, ICH/GCP Guidelines, and other applicable regulatory requirements.

Nice To Haves

Experience in both people management and program management.

Responsibilities

Build, develop, and retain global gCSM teams, including hiring, training, mentoring, performance appraisals, and resource management for direct and indirect reports.
Oversee project delivery and goal achievement within designated programs and act as the escalation point for issues gCSMs cannot resolve.
Collaborate with other GCPLs to define and implement cross-program strategies and priorities, and establish global standards for gCSM goals, performance measures, and capability development.
Represent GCO in designated programs and provide clinical operations insight to governance teams, including Franchise ERC and DCT, in coordination with the Franchise Head.
Lead or participate in KOL engagement activities and serve as a functional spokesperson when needed.
Develop strategic feasibility assessments and budget estimates during early planning for new CDPs and when study strategies change.
Manage resource allocation and initiate CST formation, ensuring outputs from early planning are appropriately transitioned to gCSMs.
Develop annual program budgets and resource forecasts and contribute to and track relevant DCT goals.
Create, review, contribute to, and maintain compound-level documents, including IBs, DSURs, and protocols.
Oversee timely, high-quality, and efficient planning and execution of associated studies within the program.
Conduct regular program reviews, mentor and support study teams, and ensure studies track to DCT/DRC-approved budgets and timelines.
Report study status, goals, and operational KPIs, and enforce quality KPIs with Compliance team support.
Collaborate with other GCPLs to evaluate and designate preferred global vendors and participate in vendor governance meetings.
Create or review direct reports’ performance and development plans and support achievement of their goals.
Provide line management and mentorship to gCSMs in designated programs.
Promote scientific knowledge within Clinical Operations and champion a global mindset, collaboration, and consistency.
Apply expertise in clinical trial execution, ICH/GCP Guidelines, and other applicable regulatory requirements.
Serve as the escalation point for compound-related issues.
Identify and drive process improvement initiatives with the Franchise Head and/or other GCPLs.
Collaborate with cross-functional leaders to provide operational perspectives that support effective delivery of clinical development goals.